Eli Lilly and Company

NYSE:LLY Stock Report

Market Cap: US$920.0b

Eli Lilly Future Growth

Future criteria checks 5/6

Eli Lilly is forecast to grow earnings and revenue by 21.9% and 14.4% per annum respectively. EPS is expected to grow by 21.5% per annum. Return on equity is forecast to be 52% in 3 years.

Key information

21.9%

Earnings growth rate

21.45%

EPS growth rate

Pharmaceuticals earnings growth13.8%
Revenue growth rate14.4%
Future return on equity52.03%
Analyst coverage

Good

Last updated12 Dec 2025

Recent future growth updates

Eli Lilly and Company Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

May 05
Eli Lilly and Company Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Recent updates

Mounjaro In China: Assessing Market Potential And Risks

Dec 09

Investors Appear Satisfied With Eli Lilly and Company's (NYSE:LLY) Prospects As Shares Rocket 30%

Nov 25
Investors Appear Satisfied With Eli Lilly and Company's (NYSE:LLY) Prospects As Shares Rocket 30%

Eli Lilly (NYSE:LLY) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 07
Eli Lilly (NYSE:LLY) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Eli Lilly's Future Growth Driven by Tirzepatide and Favorable Market Conditions

Catalysts Mounjaro/Zepbound: Lilly’s tirzepatide franchise is the engine of growth. Mounjaro (for type 2 diabetes) and Zepbound (obesity) each grew rapidly in 2024.

Eli Lilly and Company Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

May 05
Eli Lilly and Company Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Eli Lilly: Why Orforglipron Matters, A Lot

Apr 28

Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging

Apr 20

Eli Lilly: A Safe Harbor Amid Market Volatility

Mar 17

Earnings and Revenue Growth Forecasts

NYSE:LLY - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202789,12134,45725,47932,28825
12/31/202676,29828,04817,47825,79129
12/31/202563,57820,39911,21519,15625
9/30/202559,42018,4127,03816,062N/A
6/30/202553,25813,80055110,938N/A
3/31/202549,00311,106-6689,318N/A
12/31/202445,04310,5901,0168,818N/A
9/30/202440,8638,370-2,2756,032N/A
6/30/202438,9237,342-2,0244,510N/A
3/31/202435,9326,138-2,2923,676N/A
12/31/202334,1245,240-1,5484,240N/A
9/30/202332,0734,9881,4696,215N/A
6/30/202329,5166,4983,3076,242N/A
3/31/202327,6915,6873,8816,793N/A
12/31/202228,5416,2454,6967,586N/A
9/30/202229,2406,0335,4048,080N/A
6/30/202229,0715,6924,9507,494N/A
3/31/202229,3236,1295,8248,086N/A
12/31/202128,3185,5825,6047,366N/A
9/30/202127,7595,9724,6216,919N/A
6/30/202126,7266,0714,8377,095N/A
3/31/202125,4866,0935,5657,815N/A
12/31/202024,5406,1944,4716,500N/A
9/30/202023,2145,5735,1126,648N/A
6/30/202022,9505,6184,8906,352N/A
3/31/202023,0875,5333,6844,908N/A
12/31/201922,3204,6383,4834,837N/A
9/30/201921,8434,2642,6714,322N/A
6/30/201921,6734,103N/A4,933N/A
3/31/201921,6222,545N/A5,399N/A
12/31/201821,4933,151N/A5,525N/A
9/30/201822,016372N/A5,819N/A
6/30/201822,368-166N/A5,579N/A
3/31/201822,6071,074N/A5,712N/A
12/31/201719,974-86N/A5,616N/A
9/30/201722,4712,225N/A5,879N/A
6/30/201722,0052,447N/A5,659N/A
3/31/201721,5852,187N/A5,410N/A
12/31/201621,2222,738N/A4,851N/A
9/30/201620,8372,444N/A3,841N/A
6/30/201620,6052,466N/A3,284N/A
3/31/201620,1792,319N/A2,830N/A
12/31/201519,9592,408N/A2,965N/A
9/30/201519,7042,359N/A3,318N/A
6/30/201519,6202,059N/A3,905N/A
3/31/201519,5772,192N/A4,010N/A
12/31/201419,6162,391N/A4,458N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LLY's forecast earnings growth (21.9% per year) is above the savings rate (3.3%).

Earnings vs Market: LLY's earnings (21.9% per year) are forecast to grow faster than the US market (16.1% per year).

High Growth Earnings: LLY's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: LLY's revenue (14.4% per year) is forecast to grow faster than the US market (10.6% per year).

High Growth Revenue: LLY's revenue (14.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: LLY's Return on Equity is forecast to be very high in 3 years time (52%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/14 02:37
End of Day Share Price 2025/12/12 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Eli Lilly and Company is covered by 53 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Luisa HectorBerenberg
Kerry HolfordBerenberg